在肺癌进展过程中通过流细胞测量对肺部输液中细胞DNA含量的分析:一个案例报告

Maria M Vasilescu1, Marieta E Panait2, Mirela Dumitru1

  • 1Department of Cancer Biochemistry and Radiobiology, Institutul Oncologic Prof. Dr. Alexandru Trestioreanu, Bucharest, ROU.

Cureus
|January 22, 2025
PubMed
概括

恶性流 (MPE) 揭示了癌症治疗期间的瘤细胞动态. 流细胞测量显示,出现了耐治疗细胞,在肺腺癌患者中推动了疾病的进展.